January 22, 2018 ORPHAN DRUG DESIGNATION GRANTED TO POTENTIAL ACUTE RADIATION SYNDROME TREATMENT Explore further
January 19, 2018 ENZYCHEM LIFESCIENCES ANNOUNCES THE FDA ORPHAN DRUG DESIGNATION GRANTED TO EC-18 ON ACUTE RADIATION SYNDROME (ARS) Explore further
December 5, 2017 A BILLION DOLLAR MARKET JUST WAITING FOR A NEW ORAL MUCOSITIS DRUG: FIVE COMPANIES THAT WANT IT Explore further
